MED14 and CRSP150 Interaction: A Crucial Regulator of Gene Expression

Target Name: MED14

NCBI ID: G9282

MED14

MED14 and CRSP150 Interaction: A Crucial Regulator of Gene Expression

MED14 (Transcriptional co-activator CRSP150) is a protein that plays a crucial role in the regulation of gene expression in various organisms, including humans. MED14 is a key transcription factor that can interact with DNA to control the expression of genes. It is a transactional co-activator, which means that it interacts with other transcription factors to enhance their activity.

CRSP150 is a non-coding RNA molecule that can interact with MED14 to enhance its transcriptional activity. This interaction between MED14 and CRSP150 is critical for the regulation of gene expression.

MED14 and CRSP150 Interaction

MED14 is a 22 kDa protein that is composed of two distinct subunits, alpha and beta. The alpha subunit has a molecular weight of 42 kDa, while the beta subunit has a molecular weight of 21 kDa. Both subunits contain a N-terminal transmembrane domain , a coiled-coil domain, and a C-terminal DNA-binding domain.

CRSP150 is a non-coding RNA molecule that has a molecular weight of 18.5 kDa. It consists of a single exon that encodes a 191-amino acid protein.

The interaction between MED14 and CRSP150 occurs through a process called co-regulation. This interaction is critical for the regulation of gene expression, as it allows MED14 to enhance the transcriptional activity of CRSP150.

MED14 Interacts with CRSP150

MED14 and CRSP150 share a common binding site in their respective N-termini. This interaction between MED14 and CRSP150 allows both molecules to enhance the transcriptional activity of each other.

The interaction between MED14 and CRSP150 is achieved through the formation of a ternary complex. In this complex, CRSP150 is located in the active center of MED14, forming a helical structure composed of CRSP150 at the N-terminus. This structure allows CRSP150 to form a tight interaction with the active center of MED14, thereby enhancing the transcriptional activity of MED14.

The interaction between MED14 and CRSP150 also shows that it enhances the transcriptional activity of CRSP150. When MED14 binds to CRSP150, it enhances the binding of CRSP150 to DNA, leading to increased translation levels of CRSP150. This enhanced translation level feeds back to MED14, further enhancing its transcriptional activity.

The interaction between MED14 and CRSP150 results in the regulation of gene expression. For example, MED14 can promote the expression of certain genes by enhancing the transcriptional activity of CRSP150, while inhibiting the expression of other genes by enhancing the degradation of CRSP150.

The relationship between MED14 and CRSP150 also indicates that in some diseases, the imbalance of MED14 and CRSP150 may lead to the occurrence of the disease. For example, dysregulation of MED14 has been linked to cancer, while dysregulation of CRSP150 is also considered a hallmark of many diseases, such as neurodegenerative diseases, diabetes, and obesity.

The relationship between MED14 and CRSP150 is of great significance to the study of molecular biology. Through in-depth study of the interaction between MED14 and CRSP150, we can better understand the regulatory mechanism of gene expression and provide targets for the development of new drugs.

Conclusion

The interaction between MED14 and CRSP150 is an important research topic, which can conduct in-depth research on the regulatory mechanism of gene expression and provide targets for the development of new drugs. Through in-depth study of the interaction between MED14 and CRSP150, more regulatory mechanisms related to gene expression can be revealed, bringing new progress to medicine.

Protein Name: Mediator Complex Subunit 14

Functions: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors

The "MED14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MED14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets